Drug Pipeline

Anetumab Ravtansine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
0
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT03587311 Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory… Fallopian Tube Endometrioid Adenocarcinoma Active, Not Recruiting
Phase 1/2
NCT03126630 Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With… Pleural Malignant Mesothelioma Active, Not Recruiting
Phase 1
NCT03816358 Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and… Pancreatic Adenocarcinoma Active, Not Recruiting
Sponsors Running Anetumab Ravtansine Trials
National Cancer Institute (NCI) (3)
Disease Areas
Mesothelioma (1) Ovarian Cancer (1) Pancreatic Cancer (1)
Get alerts when Anetumab Ravtansine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free